drugset / Trial / NCT00603187

ACY-7 Oral Administration of Acyline

NCT00603187

NaSingle-groupOpen-labelTreatment

Summary

We propose oral dosing of gastrointestinal permeation enhancement technology \[GIPET\] enhanced oral acyline at 20 mg everyday for one week to determine the steady-state (multiple-dose) pharmacokinetics of oral acyline in four normal, healthy young men.

Timeline

Start
2008-01
Primary completion
2008-02
Completion
2008-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acyline Protein / enzyme biologic 20 mg Oral

Indications

No indication recorded.